StonvexLoading…
StonvexCore line items from AMWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $1.71B | $1.85B | $2.07B | $1.86B |
Operating Income | $140.24M | $161.39M | $136.35M | $36.16M |
Net Income | $99.46M | $116.22M | $93.72M | $-29.72M |
EPS (Diluted) | $6.50 | $7.15 | $5.62 | $-1.79 |
Total Assets | $1.57B | $1.59B | $1.52B | $1.63B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $48.20M | $87.40M | $41.73M | $22.32M |
Free Cash Flow OCF − CapEx | $68.73M | $139.70M | $156.24M | $-19.68M |
Shares Outstanding | 14.61M | 15.65M | 16.64M | 16.57M |